SCHEMBL6155264

SCHEMBL6155264

COC(=O)C(=O)Nc1ccc(CN(c2ccc(Cl)c(Cl)c2)c2nnc(-c3cccc(Oc4cccc(C(F)(F)F)c4)c3)s2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 2/20 0.40
P2RY1 P47900 5/20 0.40
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 1/20 0.36
CACNA1B Q00975 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154990 0.93 P2RY1 (0.40) CETPP2RY1TLR8TLR7TP53
SCHEMBL6680592 0.90 LMNA (0.42) CETPP2RY1TP53MAPTRXFP1
SCHEMBL6154582 0.89 CETP (0.41) CETPP2RY1TP53MAPTRXFP1
SCHEMBL6153971 0.86 S1PR1 (0.40) CETPP2RY1HPGDHSD17B10NPC1
SCHEMBL6155267 0.85 HSD17B10 (0.40) P2RY1TLR7HPGDHSD17B10NPC1
SCHEMBL6154252 0.85 GCGR (0.39) MAPTHPGDHSD17B10NPC1LMNA
SCHEMBL6155070 0.78 PTPN5 (0.45) HPGDHSD17B10NPC1LMNAROCK2
SCHEMBL6155036 0.78 HSD17B10 (0.38) P2RY1TLR8TLR7HPGDHSD17B10
SCHEMBL6678797 0.78 GCGR (0.35) HPGDHSD17B10NPC1LMNAALDH1A1
SCHEMBL6678801 0.77 HSD17B10 (0.35) HPGDHSD17B10NPC1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP CETP 4049/4885P2RY1 2072/4885TLR8 3964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.